real alternative medicine for small cell lung cancer

Therefore, integrative oncology is expected to be increasingly adopted so as to strengthen anticancer effects and control symptoms. In this respect, CAM has increasingly been added to the therapeutic modalities used to treat patients with lung cancer in the hope of enhancing the body's ability to fight the cancer and promoting the patient's wellness. As advanced supportive care, complementary and alternative medicine (CAM) therapies are recommended to intensify holistic and tailored approached by integrating them with conventional cancer treatments (CCTs). Various cancer therapies, especially those used for patients with advanced and metastatic cancers, are coordinated and mainly focus on stabilizing the disease and managing cancer-related symptoms. Although the mortality rates for patients with lung cancer continue to decline due to reductions in smoking, early diagnosis, and advances in treatment, in Korea, lung cancer was still the leading cause of cancer death in both men and women in 2014, with 5-year relative survival rates of 21.9% for men and 32.4% for women. Lung cancer is the most frequently diagnosed cancer, with the highest incident rates occurring in Central and Eastern Europe and in Eastern Asia. To clarify the impacts of ICT for lung cancer and other cancers on survival outcome, further prospective study with a rigorous study design is required in multiclinical setting.

Even though this study has limitations including heterogeneity between treatment groups, the study results suggest that ICT has positive effect on survival probability. The results suggest that integration of TKM and conventional cancer treatment may have survival benefits in patients with lung cancer. After adjusting confounders, the mortality rate of integrative group was reduced by 6% compared to mono-TKM group, suggesting positive effect on survival probability of integrative group. In the unadjusted model, for patients in the integrative group, the mortality rate was reduced by 50% compared to mono-TKM group with statistical significance. Patients with advanced stage had significantly higher mortality than patients with early stage (crude hazard ratio : 4.41, 95% confidence interval : 1.56–12.5 adjusted HR: 6.31, 95% CI: 1.24–32.1). Of those patients, 45.1% were in the mono-TKM group and 39.6% were integrative group. A descriptive analysis of the characteristics and a survival analysis using the Kaplan-Meier curves with log rank test and a Cox proportional hazard model were performed.Ī total of 91 patients were included, and the majority had advanced-stage cancer.

We classified the patients into groups according to their ICT and whether or not they underwent anticancer traditional Korean Medicine treatment with a multiherbal formula containing Panax notoginseng Radix, Cordyceps militaris, P ginseng C.A.Mey., and Boswellia carterii BIRDWOOD (HangAmDan-B), with a herbal formula containing Rhus verniciflua Stoke, or with cultivated wild ginseng pharmacopuncture. We reviewed medical records for lung cancer patients who visited a single integrative clinical setting, East-West Cancer Center, between January 2014 and December 2015. The objective of this study is to identify the characteristics of patients with lung cancer treated at an integrative cancer center in Korea and to determine the effects of integrative cancer treatment (ICT) on survival outcome in traditional Korean medicine (TKM). Integrative oncology is being increasingly adopted in mainstream cancer care to strengthen anticancer effects and to control cancer-related symptoms.

Real alternative medicine for small cell lung cancer